Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitution

Clinical Immunology

Volumn 127, Issue 3, 2008, Pages 286-297

  Brown, Julia A ^a   Boussiotis, Vassiliki A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cord blood transplantation; Immune reconstitution; Post transplant infections; Tolerance

Indexed keywords

ANTIGEN; ANTINEOPLASTIC AGENT; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 2; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA;

BONE MARROW DEPRESSION; CANCER PATIENT; CANCER RELAPSE; CELL PROLIFERATION; CELL SUBPOPULATION; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; INCIDENCE; INTERFERON PRODUCTION; LEUKEMIA; LYMPHOMA; MINORITY GROUP; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHORT SURVEY; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

B-LYMPHOCYTES; CLINICAL TRIALS AS TOPIC; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; GRAFT VS HOST DISEASE; HUMANS; T-LYMPHOCYTE SUBSETS;

EID: 45249101091     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.02.008     Document Type: Short Survey

References (78)

1. Barker J.N., and Wagner J.E. Umbilical-cord blood transplantation for the treatment of cancer. Nat. Rev., Cancer 3 (2003) 526-532
2. Knudtzon S. In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 43 (1974) 357-361
3. Broxmeyer H.E., Douglas G.W., Hangoc G., Cooper S., Bard J., English D., Arny M., Thomas L., and Boyse E.A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 3828-3832
4. Gluckman E., Broxmeyer H.A., Auerbach A.D., Friedman H.S., Douglas G.W., Devergie A., Esperou H., Thierry D., Socie G., Lehn P., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321 (1989) 1174-1178
5. Barker J.N., and Wagner J.E. Umbilical cord blood transplantation: current practice and future innovations. Crit. Rev. Oncol./Hematol. 48 (2003) 35-43
6. Rocha V., Wagner Jr. J.E., Sobocinski K.A., Klein J.P., Zhang M.J., Horowitz M.M., and Gluckman E. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N. Engl. J. Med. 342 (2000) 1846-1854
7. Gluckman E., Rocha V., Boyer-Chammard A., Locatelli F., Arcese W., Pasquini R., Ortega J., Souillet G., Ferreira E., Laporte J.P., Fernandez M., and Chastang C. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N. Engl. J. Med. 337 (1997) 373-381
8. Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A.R., Berkowitz R.L., Cabbad M., Dobrila N.L., Taylor P.E., Rosenfield R.E., and Stevens C.E. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl. J. Med. 339 (1998) 1565-1577
9. Wagner J.E., Rosenthal J., Sweetman R., Shu X.O., Davies S.M., Ramsay N.K., McGlave P.B., Sender L., and Cairo M.S. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 88 (1996) 795-802
10. Dalle J.H., Duval M., Moghrabi A., Wagner E., Vachon M.F., Barrette S., Bernstein M., Champagne J., David M., Demers J., Rousseau P., Winikoff R., and Champagne M.A. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant. 33 (2004) 605-611
11. Barker J.N., Davies S.M., DeFor T., Ramsay N.K., Weisdorf D.J., and Wagner J.E. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97 (2001) 2957-2961
12. Rocha V., Cornish J., Sievers E.L., Filipovich A., Locatelli F., Peters C., Remberger M., Michel G., Arcese W., Dallorso S., Tiedemann K., Busca A., Chan K.W., Kato S., Ortega J., Vowels M., Zander A., Souillet G., Oakill A., Woolfrey A., Pay A.L., Green A., Garnier F., Ionescu I., Wernet P., Sirchia G., Rubinstein P., Chevret S., and Gluckman E. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97 (2001) 2962-2971
13. Rocha V., Labopin M., Sanz G., Arcese W., Schwerdtfeger R., Bosi A., Jacobsen N., Ruutu T., de Lima M., Finke J., Frassoni F., and Gluckman E. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl. J. Med. 351 (2004) 2276-2285
14. Laughlin M.J., Eapen M., Rubinstein P., Wagner J.E., Zhang M.J., Champlin R.E., Stevens C., Barker J.N., Gale R.P., Lazarus H.M., Marks D.I., van Rood J.J., Scaradavou A., and Horowitz M.M. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N. Engl. J. Med. 351 (2004) 2265-2275
15. Laughlin M.J., Barker J., Bambach B., Koc O.N., Rizzieri D.A., Wagner J.E., Gerson S.L., Lazarus H.M., Cairo M., Stevens C.E., Rubinstein P., and Kurtzberg J. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J. Med. 344 (2001) 1815-1822
16. Wagner J.E., Barker J.N., DeFor T.E., Baker K.S., Blazar B.R., Eide C., Goldman A., Kersey J., Krivit W., MacMillan M.L., Orchard P.J., Peters C., Weisdorf D.J., Ramsay N.K., and Davies S.M. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100 (2002) 1611-1618
17. Long G.D., Laughlin M., Madan B., Kurtzberg J., Gasparetto C., Morris A., Rizzieri D., Smith C., Vredenburgh J., Halperin E.C., Broadwater G., Niedzwiecki D., and Chao N.J. Unrelated umbilical cord blood transplantation in adult patients. Biol. Blood Marrow Transplant. 9 (2003) 772-780
18. Barker J.N., Weisdorf D.J., DeFor T.E., Blazar B.R., Miller J.S., and Wagner J.E. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102 (2003) 1915-1919
19. Cornetta K., Laughlin M., Carter S., Wall D., Weinthal J., Delaney C., Wagner J., Sweetman R., McCarthy P., and Chao N. Umbilical cord blood transplantation in adults: results of the prospective cord blood transplantation (COBLT). Biol. Blood Marrow Transplant. 11 (2005) 149-160
20. McNiece I., Kubegov D., Kerzic P., Shpall E.J., and Gross S. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp. Hematol. 28 (2000) 1181-1186
21. Lewis I.D., Almeida-Porada G., Du J., Lemischka I.R., Moore K.A., Zanjani E.D., and Verfaillie C.M. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 97 (2001) 3441-3449
22. Peled T., Landau E., Mandel J., Glukhman E., Goudsmid N.R., Nagler A., and Fibach E. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp. Hematol. 32 (2004) 547-555
23. Nauta A.J., Kruisselbrink A.B., Lurvink E., Mulder A., Claas F.H., Noort W.A., Willemze R., and Fibbe W.E. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Exp. Hematol. 33 (2005) 1249-1256
24. Barker J.N., Weisdorf D.J., DeFor T.E., Blazar B.R., McGlave P.B., Miller J.S., Verfaillie C.M., and Wagner J.E. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105 (2005) 1343-1347
25. Ballen K.K., Spitzer T.R., Yeap B.Y., McAfee S., Dey B.R., Attar E., Haspel R., Kao G., Liney D., Alyea E., Lee S., Cutler C., Ho V., Soiffer R., and Antin J.H. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol. Blood Marrow Transplant. 13 (2007) 82-89
26. Brunstein C.G., Barker J.N., Weisdorf D.J., DeFor T.E., Miller J.S., Blazar B.R., McGlave P.B., and Wagner J.E. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110 (2007) 3064-3070
27. Ting D.T., Ballen K., Spitzer T.R., Haspel R.L., Dorn M., Preffer F., Boussiotis V., McAfee S., Attar E., Antin J.H., Soiffer R.J., Cutler C., Ho V., and Dey B.R. Effects of cord blood cell subset populations in the development of the dominant cord blood unit in non-myeloablative sequential double cord blood transplantation (DCBT). Blood 108 (2006) (supp): abstract
28. Michel G., Rocha V., Chevret S., Arcese W., Chan K.W., Filipovich A., Takahashi T.A., Vowels M., Ortega J., Bordigoni P., Shaw P.J., Yaniv I., Machado A., Pimentel P., Fagioli F., Verdeguer A., Jouet J.P., Diez B., Ferreira E., Pasquini R., Rosenthal J., Sievers E., Messina C., Iori A.P., Garnier F., Ionescu I., Locatelli F., and Gluckman E. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 102 (2003) 4290-4297
29. Kadereit S., Deeds L.S., Haynesworth S.E., Koc O.N., Kozik M.M., Szekely E., Daum-Woods K., Goetchius G.W., Fu P., Welniak L.A., Murphy W.J., and Laughlin M.J. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer. Stem Cells 20 (2002) 573-582
30. Chalmers I.M., Janossy G., Contreras M., and Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 92 (1998) 11-18
31. Liu E., Law H.K., and Lau Y.L. Tolerance associated with cord blood transplantation may depend on the state of host dendritic cells. Br. J. Haematol. 126 (2004) 517-526
32. Brahmi Z., Hommel-Berrey G., Smith F., and Thomson B. NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients. Hum. Immunol. 62 (2001) 782-790
33. Kadereit S., Mohammad S.F., Miller R.E., Woods K.D., Listrom C.D., McKinnon K., Alali A., Bos L.S., Iacobucci M.L., Sramkoski M.R., Jacobberger J.W., and Laughlin M.J. Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood 94 (1999) 3101-3107
34. Howrey R.P., Martin P.L., Driscoll T., Szabolcs P., Kelly T., Shpall E.J., Bearman S.I., Slat-Vasquez V., Rubinstein P., Stevens C.E., and Kurtzberg J. Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia. Bone Marrow Transplant. 26 (2000) 1251-1254
35. Cohen G., Carter S.L., Weinberg K.I., Masinsin B., Guinan E., Kurtzberg J., Wagner J.E., Kernan N.A., and Parkman R. Antigen-specific T-lymphocyte function after cord blood transplantation. Biol. Blood Marrow Transplant. 12 (2006) 1335-1342
36. Paulin T. Importance of bone marrow cell dose in bone marrow transplantation. Clin. Transplant. 6 (1992) 48-54
37. Wagner J.E., and Kurtzberg J. Cord blood stem cells. Curr. Opin. Hematol. 4 (1997) 413-418
38. Faber L.M., van Luxemburg-Heijs S.A., Veenhof W.F., Willemze R., and Falkenburg J.H. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. Blood 86 (1995) 2821-2828
39. Faber L.M., van Luxemburg-Heijs S.A., Willemze R., and Falkenburg J.H. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J. Exp. Med. 176 (1992) 1283-1289
40. Falkenburg J.H., Faber L.M., van den Elshout M., van Luxemburg-Heijs S.A., Hooftman-den Otter A., Smit W.M., Voogt P.J., and Willemze R. Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantation. J. Immunother. Emphas. Tumor. Immunol. 14 (1993) 305-309
41. Mommaas B., Stegehuis-Kamp J.A., van Halteren A.G., Kester M., Enczmann J., Wernet P., Kogler G., Mutis T., Brand A., and Goulmy E. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood 105 (2005) 1823-1827
42. Ruggeri L., Capanni M., Casucci M., Volpi I., Tosti A., Perruccio K., Urbani E., Negrin R.S., Martelli M.F., and Velardi A. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94 (1999) 333-339
43. Flomenberg N., Baxter-Lowe L.A., Confer D., Fernandez-Vina M., Filipovich A., Horowitz M., Hurley C., Kollman C., Anasetti C., Noreen H., Begovich A., Hildebrand W., Petersdorf E., Schmeckpeper B., Setterholm M., Trachtenberg E., Williams T., Yunis E., and Weisdorf D. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104 (2004) 1923-1930
44. Gomi S., Hasegawa S., Dan K., and Wakabayashi I. A comparative analysis of the transplant potential of umbilical cord blood versus mobilized peripheral blood stem cells. Nippon Ika Daigaku Zasshi 64 (1997) 307-313
45. Ng Y.Y., van Kessel B., Lokhorst H.M., Baert M.R., van den Burg C.M., Bloem A.C., and Staal F.J. Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity. J. Leukoc. Biol. 75 (2004) 314-323
46. Theunissen K., and Verfaillie C.M. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. Exp. Hematol. 33 (2005) 165-172
47. Roy V., and Verfaillie C.M. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp. Hematol. 27 (1999) 302-312
48. Peled A., Kollet O., Ponomaryov T., Petit I., Franitza S., Grabovsky V., Slav M.M., Nagler A., Lider O., Alon R., Zipori D., and Lapidot T. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95 (2000) 3289-3296
49. Zheng Y., Watanabe N., Nagamura-Inoue T., Igura K., Nagayama H., Tojo A., Tanosaki R., Takaue Y., Okamoto S., and Takahashi T.A. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Exp. Hematol. 31 (2003) 1237-1246
50. Fernandez M.N., Regidor C., Cabrera R., Garcia-Marco J.A., Fores R., Sanjuan I., Gayoso J., Gil S., Ruiz E., Little A.M., McWhinnie A., and Madrigal A. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp. Hematol. 31 (2003) 535-544
51. Shpall E.J., Quinones R., Giller R., Zeng C., Baron A.E., Jones R.B., Bearman S.I., Nieto Y., Freed B., Madinger N., Hogan C.J., Slat-Vasquez V., Russell P., Blunk B., Schissel D., Hild E., Malcolm J., Ward W., and McNiece I.K. Transplantation of ex vivo expanded cord blood. Biol. Blood Marrow Transplant. 8 (2002) 368-376
52. Kollet O., Peled A., Byk T., Ben-Hur H., Greiner D., Shultz L., and Lapidot T. beta2 Microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95 (2000) 3102-3105
53. Jaroscak J., Goltry K., Smith A., Waters-Pick B., Martin P.L., Driscoll T.A., Howrey R., Chao N., Douville J., Burhop S., Fu P., and Kurtzberg J. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 101 (2003) 5061-5067
54. Baddley J.W., Salzman D., and Pappas P.G. Fungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical features. Clin. Transplant. 16 (2002) 419-424
55. Baddley J.W., Stroud T.P., Salzman D., and Pappas P.G. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin. Infect. Dis. 32 (2001) 1319-1324
56. Collin B.A., Leather H.L., Wingard J.R., and Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin. Infect. Dis. 33 (2001) 947-953
57. Haque T., Taylor C., Wilkie G.M., Murad P., Amlot P.L., Beath S., McKiernan P.J., and Crawford D.H. Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation 72 (2001) 1399-1402
58. Crawford D.H., Mulholland N., Iliescu V., Hawkins R., and Powles R. Epstein-Barr virus infection and immunity in bone marrow transplant recipients. Transplantation 42 (1986) 50-54
59. van Kraaij M.G., Verdonck L.F., Rozenberg-Arska M., and Dekker A.W. Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence. Bone Marrow Transplant. 30 (2002) 303-309
60. Hamza N.S., Lisgaris M., Yadavalli G., Nadeau L., Fox R., Fu P., Lazarus H.M., Koc O.N., Salata R.A., and Laughlin M.J. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br. J. Haematol. 124 (2004) 488-498
61. Yoo J.H., Lee D.G., Choi S.M., Choi J.H., Park Y.H., Kim Y.J., Kim H.J., Lee S., Kim D.W., Lee J.W., Min W.S., Shin W.S., and Kim C.C. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant. 34 (2004) 497-504
62. Locatelli F., Maccario R., Comoli P., Bertolini F., Giorgiani G., Montagna D., Bonetti F., De Stefano P., Rondini G., Sirchia G., and Severi F. Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children. Bone Marrow Transplant. 18 (1996) 1095-1101
63. Thomson B.G., Robertson K.A., Gowan D., Heilman D., Broxmeyer H.E., Emanuel D., Kotylo P., Brahmi Z., and Smith F.O. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 96 (2000) 2703-2711
64. Klein A.K., Patel D.D., Gooding M.E., Sempowski G.D., Chen B.J., Liu C., Kurtzberg J., Haynes B.F., and Chao N.J. T-Cell recovery in adults and children following umbilical cord blood transplantation. Biol. Blood Marrow Transplant. 7 (2001) 454-466
65. Inoue H., Yasuda Y., Hattori K., Shimizu T., Matsumoto M., Yabe M., Yabe H., Tsuchida F., Tanaka Y., Hosoi G., Sako M., and Kato S. The kinetics of immune reconstitution after cord blood transplantation and selected CD34+ stem cell transplantation in children: comparison with bone marrow transplantation. Int. J. Hematol. 77 (2003) 399-407
66. Giraud P., Thuret I., Reviron D., Chambost H., Brunet C., Novakovitch G., Farnarier C., and Michel G. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience. Bone Marrow Transplant. 25 (2000) 53-57
67. Roux E., Helg C., Dumont-Girard F., Chapuis B., Jeannet M., and Roosnek E. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 87 (1996) 3984-3992
68. Kook H., Goldman F., Giller R., Goeken N., Peters C., Comito M., Rumelhart S., Holida M., Lee N., and Trigg M. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation. Clin. Diagn. Lab. Immunol. 4 (1997) 96-103
69. Foot A.B., Potter M.N., Donaldson C., Cornish J.M., Wallington T.B., Oakhill A., and Pamphilon D.H. Immune reconstitution after BMT in children. Bone Marrow Transplant. 11 (1993) 7-13
70. Pavletic Z.S., Joshi S.S., Pirruccello S.J., Tarantolo S.R., Kollath J., Reed E.C., Bierman P.J., Vose J.M., Warkentin P.I., Gross T.G., Nasrati K., Armitage J.O., Kessinger A., and Bishop M.R. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant. 21 (1998) 33-41
71. Gratama J.W., Fibbe W.E., Visser J.W., Kluin-Nelemans H.C., Ginsel L.A., and Bolhuis R.L. CD3+, 4+ and/or 8+ T cells and CD3+, 4-, 8- T cells repopulate at different rates after allogeneic bone marrow transplantation. Bone Marrow Transplant. 4 (1989) 291-296
72. Ault K.A., Antin J.H., Ginsburg D., Orkin S.H., Rappeport J.M., Keohan M.L., Martin P., and Smith B.R. Phenotype of recovering lymphoid cell populations after marrow transplantation. J. Exp. Med. 161 (1985) 1483-1502
73. Hercend T., Takvorian T., Nowill A., Tantravahi R., Moingeon P., Anderson K.C., Murray C., Bohuon C., Ythier A., and Ritz J. Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 67 (1986) 722-728
74. Saavedra S., Jarque I., Sanz G.F., Moscardo F., Jimenez C., Martin G., Plume G., Regadera A., Martinez J., De La Rubia J., Acosta B., Peman J., Perez-Belles C., Gobernado M., and Sanz M.A. Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution. Clin. Microbiol. Infect. 8 (2002) 725-733
75. Tomonari A., Iseki T., Ooi J., Takahashi S., Shindo M., Ishii K., Nagamura F., Uchimaru K., Tani K., Tojo A., and Asano S. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. Br. J. Haematol. 121 (2003) 304-311
76. Godfrey W.R., Spoden D.J., Ge Y.G., Baker S.R., Liu B., Levine B.L., June C.H., Blazar B.R., and Porter S.B. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105 (2005) 750-758
77. Li L., Godfrey W.R., Porter S.B., Ge Y., June C.H., Blazar B.R., and Boussiotis V.A. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106 (2005) 3068-3073
78. Cairo M.S., and Wagner J.E. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 90 (1997) 4665-4678